Your account is not claimed yet. You can sign up with ORCID to claim your account.

He Huang

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 61

Top Venues

Bone marrow transplantation

Stem cell research & therapy

British journal of haematology

Journal of translational medicine

Zhejiang University

Zhejiang University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zhejiang University

China

Professor :: School of Medicine

Education History

Zhejiang University

China

PHD

Publications

Fengmei Song, Yongxian Hu, Yanlei Zhang, Mingming Zhang, Tingting Yang, Wenjun Wu, Simao Huang, Huijun Xu, Alex H Chang, He Huang, Guoqing Wei
Safety and efficacy of autologous and allogeneic humanized CD19-targeted CAR-T cell therapy for patients with relapsed/refractory B-ALL. Journal for immunotherapy of cancer 11 (2) (2023)
Hengwei Wu, Yeqian Zhao, Fei Gao, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Pengxu Qian, He Huang, Yanmin Zhao
Haploidentical transplants deliver equal outcomes to matched sibling transplants: a propensity score-matched analysis. Journal of translational medicine 21 (1) (2023)
Shan Fu, Qiqi Zhang, Ruirui Jing, Cheng Zu, Fang Ni, Yuqi Lv, Jiazhen Cui, Haiqiong Zheng, Yanlei Zhang, Mingming Zhang, Guoqing Wei, Zenan Cen, Alex H Chang, Yongxian Hu, He Huang
HBV reactivation in patients with chronic or resolved HBV infection following BCMA-targeted CAR-T cell therapy. Bone marrow transplantation (2023)
Xiao-Lin Yuan, Xiao-Yu Lai, Yi-Bo Wu, Lu-Xin Yang, Ji-Min Shi, Li-Zhen Liu, Jian Yu, Yan-Min Zhao, Wei-Yan Zheng, Jing-Song He, Jie Sun, Wen-Jun Wu, Yi Zhao, Yi-Shan Ye, Zhen Cai, He Huang, Yi Luo
A novel risk model for predicting early relapse in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem-cell transplantation. Bone marrow transplantation (2023)
Xia Li, Chentao Li, Wanying Zhang, Yanan Wang, Pengxu Qian, He Huang
Inflammation and aging: signaling pathways and intervention therapies. Signal transduction and targeted therapy 8 (1) (2023)
Honghu Li, Qian Luo, Shuyang Cai, Ruxiu Tie, Ye Meng, Wei Shan, Yulin Xu, Xiangjun Zeng, Pengxu Qian, He Huang
Glia maturation factor-γ is required for initiation and maintenance of hematopoietic stem and progenitor cells. Stem cell research & therapy 14 (1) (2023)
Honghu Li, Qian Luo, Shuyang Cai, Ruxiu Tie, Ye Meng, Wei Shan, Yulin Xu, Xiangjun Zeng, Pengxu Qian, He Huang
Glia maturation factor-γ is required for initiation and maintenance of hematopoietic stem and progenitor cells. Stem cell research & therapy 14 (1) (2023)
Haiqiong Zheng, Yijin Chen, Qian Luo, Jie Zhang, Mengmeng Huang, Yulin Xu, Dawei Huo, Wei Shan, Ruxiu Tie, Meng Zhang, Pengxu Qian, He Huang
Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges. Cell regeneration (London, England) 12 (1) (2023)
Haiqiong Zheng, Yijin Chen, Qian Luo, Jie Zhang, Mengmeng Huang, Yulin Xu, Dawei Huo, Wei Shan, Ruxiu Tie, Meng Zhang, Pengxu Qian, He Huang
Correction: Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges. Cell regeneration (London, England) 12 (1) (2023)
Yang Gao, Hengwei Wu, Zhuoyue Shi, Fei Gao, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Huarui Fu, Lizhen Liu, He Huang, Yanmin Zhao
Prognostic factors and clinical outcomes in patients with relapsed acute leukemia after allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation (2023)
Hengwei Wu, Yeqian Zhao, Fei Gao, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Pengxu Qian, He Huang, Yanmin Zhao
Haploidentical transplants deliver equal outcomes to matched sibling transplants: a propensity score-matched analysis. Journal of translational medicine 21 (1) (2023)
Linnan Wu, Yi-Bo Wu, Jimin Shi, Xiaoyu Lai, Yanmin Zhao, Lizhen Liu, Jian Yu, Luxin Yang, Panpan Zhu, Weiyan Zheng, Yongxian Hu, Wenjun Wu, Yuanyuan Zhu, Zhen Cai, He Huang, Yi Luo
Survival and late mortality among patients who survived disease-free for 2 years after stem cell transplantation. British journal of haematology (2023)
Tingting Yang, Binqian Jiang, Yi Luo, Yanmin Zhao, Guifang Ouyang, Jian Yu, Jianping Lan, Ying Lu, Xiaoyu Lai, Baodong Ye, Yi Chen, Lizhen Liu, Yang Xu, Pengfei Shi, Haowen Xiao, Huixian Hu, Qunyi Guo, Huarui Fu, Yishan Ye, Xinyu Wang, Jie Sun, Weiyan Zheng, Jingsong He, Yi Zhao, Wenjun Wu, Zhen Cai, Guoqing Wei, He Huang, Jimin Shi
Comparison of the prognostic predictive value of Molecular International Prognostic Scoring System and Revised International Prognostic Scoring System in patients undergoing allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms. American journal of hematology (2023)
Yingying Li, Yixue Li, Mingming Zhang, Houli Zhao, Miaoyong Zhu, He Huang, Yongxian Hu
Donor-derived stem cell infusion for sustained pancytopenia after CD19 CAR-T therapy for relapsed patients post allogeneic stem cell transplantation. European journal of haematology (2023)
Hengwei Wu, Yeqian Zhao, Fei Gao, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Pengxu Qian, He Huang, Yanmin Zhao
Haploidentical transplants deliver equal outcomes to matched sibling transplants: a propensity score-matched analysis. Journal of translational medicine 21 (1) (2023)
Luxin Yang, Xiaoyu Lai, Ting Yang, Ying Lu, Lizhen Liu, Jimin Shi, Yanmin Zhao, Yi-Bo Wu, Yi Chen, Jian Yu, Haowen Xiao, Guifang Ouyang, Jinhua Ren, Junjie Cao, Yongxian Hu, Yamin Tan, Yishan Ye, Zhen Cai, Weiqun Xu, He Huang, Yi Luo
Prophylactic versus Preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study. Bone marrow transplantation (2023)
Lizhen Liu, Xinyu Ji, Panpan Zhu, Luxin Yang, Jimin Shi, Yanmin Zhao, Xiaoyu Lai, Jian Yu, Huarui Fu, Yishan Ye, Yibo Wu, Jinping Ying, He Huang, Yi Luo
Double filtration plasmapheresis combined with rituximab for donor-specific antibody desensitization in haploidentical haematopoietic stem cell transplantation. British journal of haematology (2023)
Honghu Li, Qian Luo, Shuyang Cai, Ruxiu Tie, Ye Meng, Wei Shan, Yulin Xu, Xiangjun Zeng, Pengxu Qian, He Huang
Glia maturation factor-γ is required for initiation and maintenance of hematopoietic stem and progenitor cells. Stem cell research & therapy 14 (1) (2023)
Linghui Zhou, Weijun Fu, Shenghao Wu, Kailin Xu, Lugui Qiu, Yang Xu, Xiaojing Yan, Qing Zhang, Mingming Zhang, Linqin Wang, Ruimin Hong, Alex H Chang, Jian Yu, Shan Fu, Delin Kong, Lu Li, Ying Wang, Zhenyu Li, Huawei Jiang, Jing Huang, Zhi Liu, Na Su, Guoqing Wei, Yongxian Hu, He Huang
Derivation and validation of a novel score for early prediction of severe CRS after CAR-T therapy in haematological malignancy patients: A multi-centre study. British journal of haematology (2023)
Ji-Nuo Wang, Gaofeng Zheng, Wenjun Wu, He Huang
Follicular helper T cell: Emerging roles in lymphomagenesis. Journal of leukocyte biology (2023)
Hengwei Wu, Yeqian Zhao, Fei Gao, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Pengxu Qian, He Huang, Yanmin Zhao
Haploidentical transplants deliver equal outcomes to matched sibling transplants: a propensity score-matched analysis. Journal of translational medicine 21 (1) (2023)
Fang Ni, Elaine Tan Su Yin, Linghui Zhou, Houli Zhao, Yi Luo, Jimin Shi, Yongxian Hu, He Huang
Outcomes of CD19 chimeric antigen receptor T cell followed by haploidentical hematopoietic stem-cell transplantation in relapsed/refractory B-cell acute lymphoblastic leukemia with IKZF1 deletion. Bone marrow transplantation 57 (2) (2022)
Yue Huang, Xiaohui Si, Mi Shao, Xinyi Teng, Gang Xiao, He Huang
Rewiring mitochondrial metabolism to counteract exhaustion of CAR-T cells. Journal of hematology & oncology 15 (1) (2022)
Penglei Jiang, Zhaoru Zhang, Yongxian Hu, Zuyu Liang, Yingli Han, Xia Li, Xin Zeng, Hao Zhang, Meng Zhu, Jian Dong, He Huang, Pengxu Qian
Single-cell ATAC-seq maps the comprehensive and dynamic chromatin accessibility landscape of CAR-T cell dysfunction. Leukemia 36 (11) (2022)
Hui Wang, Danrong Shi, Penglei Jiang, Zebin Yu, Yingli Han, Zhaoru Zhang, Peihui Wang, He Huang, Hang-Ping Yao, Pengxu Qian
SARS-CoV-2 N protein potentiates host NPM1-snoRNA translation machinery to enhance viral replication. Signal transduction and targeted therapy 7 (1) (2022)
Jiqin Zhang, Yongxian Hu, Jiaxuan Yang, Wei Li, Mingming Zhang, Qingcan Wang, Linjie Zhang, Guoqing Wei, Yue Tian, Kui Zhao, Ang Chen, Binghe Tan, Jiazhen Cui, Deqi Li, Yi Li, Yalei Qi, Dongrui Wang, Yuxuan Wu, Dali Li, Bing Du, Mingyao Liu, He Huang
Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL. Nature 609 (7926) (2022)
Mengbao Du, Weiwei Chen, Ke Liu, Limengmeng Wang, Yihan Hu, Yingying Mao, Xiaohui Sun, Yi Luo, Jimin Shi, Keding Shao, He Huang, Ding Ye
The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030. Journal of oncology 2022 (2022)
Tianning Gu, Kejia Hu, Xiaohui Si, Yongxian Hu, He Huang
Mechanisms of immune effector cell-associated neurotoxicity syndrome after CAR-T treatment. WIREs mechanisms of disease 14 (6) (2022)
Yongxian Hu, Yali Zhou, Mingming Zhang, Houli Zhao, Guoqing Wei, Wengang Ge, Qu Cui, Qitian Mu, Gong Chen, Lu Han, Tingting Guo, Jiazhen Cui, Xiaoyan Jiang, Xiujun Zheng, Shuhui Yu, Xiaolong Li, Xingwang Zhang, Mingxi Chen, Xiuju Li, Ming Gao, Kang Wang, Cheng Zu, Hao Zhang, Xiaohong He, Yanbin Wang, Dongrui Wang, Jiangtao Ren, He Huang
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study. Cell research 32 (11) (2022)
Mi Shao, Xinyi Teng, Xin Guo, Hao Zhang, Yue Huang, Jiazhen Cui, Xiaohui Si, Lijuan Ding, Xiujian Wang, Xia Li, Jimin Shi, Mingming Zhang, Delin Kong, Tianning Gu, Yongxian Hu, Pengxu Qian, He Huang
Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti-Leukemia Efficacy of CAR-T Cells via SOCE-Calcineurin-NFAT and Glycolysis Pathways. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (9) (2022)
Yue Huang, Houli Zhao, Mi Shao, Linghui Zhou, Xiaoqing Li, Guoqing Wei, Wenjun Wu, Jiazhen Cui, Alex H Chang, Tao Sun, Yongxian Hu, He Huang
Predictive value of next-generation sequencing-based minimal residual disease after CAR-T cell therapy. Bone marrow transplantation 57 (8) (2022)
Yongxian Hu, Jingjing Li, Fang Ni, Zhongli Yang, Xiaohua Gui, Zhiwei Bao, Houli Zhao, Guoqing Wei, Yiyun Wang, Mingming Zhang, Ruimin Hong, Linqin Wang, Wenjun Wu, Mohamad Mohty, Arnon Nagler, Alex H Chang, Marcel R M van den Brink, Ming D Li, He Huang
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies. Nature communications 13 (1) (2022)
Jingjing Feng, Mi Shao, Yongxian Hu, He Huang
Profile of capillary-leak syndrome in patients received chimeric antigen receptor T cell therapy. Bone marrow transplantation 57 (4) (2022)
Kejia Hu, Yiyun Wang, Xinyi Teng, Yongxian Hu, He Huang
Cell subsets and cytokine dynamics in cerebrospinal fluid after CAR-T cell therapy for B-cell acute lymphoblastic leukemia with central nervous system involvement. Bone marrow transplantation 56 (12) (2021)
Kangni Wu, Li-Mengmeng Wang, Meng Liu, Yanghui Xiu, Yongxian Hu, Shan Fu, He Huang, Bing Xu, Haowen Xiao
The CD226-ERK1/2-LAMP1 pathway is an important mechanism for Vγ9Vδ2 T cell cytotoxicity against chemotherapy-resistant acute myeloid leukemia blasts and leukemia stem cells. Cancer science 112 (8) (2021)
Fei Gao, Yang Gao, Yi Luo, Jian Yu, Huarui Fu, Xiaoyu Lai, Lizhen Liu, Baodong Ye, Jianping Lan, Xiaolu Song, Ying Lu, Lieguang Chen, Yi Chen, Kang Yu, He Huang, Jimin Shi, Yanmin Zhao
Venetoclax plus hypomethylating agent for the salvage treatment of relapsing myeloid malignancies after hematopoietic stem cell transplantation: A multicenter retrospective study on behalf of the Zhejiang Cooperative Group for Blood and Marrow Transplantation. American journal of hematology (2021)
Mi Shao, Qin Yu, Xinyi Teng, Xin Guo, Guoqing Wei, Huijun Xu, Jiazhen Cui, A H Chang, Yongxian Hu, He Huang
CRS-related coagulopathy in BCMA targeted CAR-T therapy: a retrospective analysis in a phase I/II clinical trial. Bone marrow transplantation 56 (7) (2021)
Qian Luo, Honghu Li, Wei Shan, Cong Wei, Yan Long, Shuyang Cai, Xiangjun Zeng, Xue Li, Yulin Xu, Xiaoxiao Xu, Yi Luo, Pengxu Qian, He Huang
Specific Blood Cells Derived from Pluripotent Stem Cells: An Emerging Field with Great Potential in Clinical Cell Therapy. Stem cells international 2021 (2021)
Lizhen Liu, Kaimin Hu, Jingjing Feng, Huafang Wang, Shan Fu, Binsheng Wang, Limengmeng Wang, Yulin Xu, Xiaohong Yu, He Huang
The oncometabolite R-2-hydroxyglutarate dysregulates the differentiation of human mesenchymal stromal cells via inducing DNA hypermethylation. BMC cancer 21 (1) (2021)
Lin Xu, Jingjing Feng, Xiaoxiao Xu, Xiaoqing Li, Xue Li, Pengxu Qian, Yi Luo, Yanmin Zhao, Mingming Zhang, Yu Lin, He Huang
IL-17-producing γδT cells ameliorate intestinal acute graft-versus-host disease by recruitment of Gr-1+CD11b+ myeloid-derived suppressor cells. Bone marrow transplantation 56 (10) (2021)
Xia Li, Mi Shao, Xiangjun Zeng, Pengxu Qian, He Huang
Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy. Signal transduction and targeted therapy 6 (1) (2021)
Mingming Zhang, Haowen Xiao, Jimin Shi, Yamin Tan, Yanmin Zhao, Jian Yu, Xiaoyu Lai, Yongxian Hu, Weiyan Zheng, Yi Luo, He Huang
Improved survival for young acute leukemia patients following a new donor hierarchy for allogeneic hematopoietic stem cell transplantation: A phase III randomized controlled study. American journal of hematology 96 (11) (2021)
Yi-Shan Ye, Mowang Wang, Florent Malard, Jimin Shi, Ying Lu, Guifang Ouyang, Jianping Lan, Yamin Tan, Yanmin Zhao, Jian Yu, Xiaoyu Lai, Yibo Wu, Luxin Yang, Fei Gao, Mohamad Mohty, He Huang, Yi Luo
Comparison of non-first-degree related donors and first-degree related donors in haploidentical HSCT: a multi-centre retrospective analysis. Bone marrow transplantation 56 (10) (2021)
Xia Li, Mi Shao, Xiangjun Zeng, Pengxu Qian, He Huang
Correction: Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy. Signal transduction and targeted therapy 6 (1) (2021)
Yi-Bo Wu, Xiaoyu Lai, Jimin Shi, Yamin Tan, Yanmin Zhao, Jian Yu, Lizhen Liu, Wei Zhang, He Huang, Yi Luo
Effect of donor characteristics on T cell-replete haploidentical stem cell transplantation over the last 10 years at a single institution. British journal of haematology (2021)
Honghu Li, Qian Luo, Wei Shan, Shuyang Cai, Ruxiu Tie, Yulin Xu, Yu Lin, Pengxu Qian, He Huang
Biomechanical cues as master regulators of hematopoietic stem cell fate. Cellular and molecular life sciences : CMLS 78 (16) (2021)
Meng Liu, Xiujie Zhao, Wenjue Pan, Zijun Qian, Mengbao Du, Li-Mengmeng Wang, He Huang, Haowen Xiao
A novel HNRNPC-RARA fusion in acute promyelocytic leukaemia lacking PML-RARA rearrangement, sensitive to venetoclax-based therapy. British journal of haematology 195 (2) (2021)
Hao Zhang, Yongxian Hu, Mi Shao, Xinyi Teng, Penglei Jiang, Xiujian Wang, Hui Wang, Jiazhen Cui, Jian Yu, Zuyu Liang, Lijuan Ding, Yingli Han, Jieping Wei, Yulin Xu, Xiaoqing Li, Wei Shan, Jimin Shi, Yi Luo, Pengxu Qian, He Huang
Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion. Journal of hematology & oncology 14 (1) (2021)
Wei Shan, Qin Yu, Yan Long, Qian Luo, Honghu Li, Yingli Han, Yulin Xu, Shan Fu, Xiangjun Zeng, Cong Wei, Yang Gao, Xiaoqing Li, Xia Li, Lifei Zhang, Lizhen Liu, Ming Chen, Pengxu Qian, He Huang
Enhanced HSC-like cell generation from mouse pluripotent stem cells in a 3D induction system cocultured with stromal cells. Stem cell research & therapy 12 (1) (2021)
Aiyun Jin, Jingjing Feng, Guoqing Wei, Wenjun Wu, Luxin Yang, Huijun Xu, Yanlei Zhang, Jiazhen Cui, Alex Hongsheng Chang, Yongxian Hu, He Huang
CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations. Bone marrow transplantation 55 (4) (2020)
Yanmin Zhao, Hengwei Wu, Jimin Shi, Yi Luo, Xiaoqing Li, Jianping Lan, Wanmao Ni, Ying Lu, Lieguang Chen, Yamin Tan, Xiaoyu Lai, Jian Yu, He Huang
Ruxolitinib combined with etanercept induce a rapid response to corticosteroid-refractory severe acute graft vs host disease after allogeneic stem cell transplantation: Results of a multi-center prospective study. American journal of hematology 95 (9) (2020)
Jian Yu, Xinyi Ge, Yi Luo, Jimin Shi, Yamin Tan, Xiaoyu Lai, Yanmin Zhao, Yishan Ye, Yuanyuan Zhu, Weiyan Zheng, He Huang
Incidence, risk factors and outcome of extramedullary relapse after allogeneic hematopoietic stem cell transplantation in patients with adult acute lymphoblastic leukemia. Annals of hematology 99 (11) (2020)
Jimin Shi, Liqin Cao, Yi Luo, Yanmin Zhao, Yamin Tan, Jian Yu, Xiaoyu Lai, Yuanyuan Zhu, Yongxian Hu, Jingsong He, Jie Sun, Weiyan Zheng, Guoqing Wei, He Huang
Maintenance sorafenib is superior to prophylactic donor lymphocyte infusion at improving the prognosis of acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplication after allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation 56 (1) (2020)
Hao Zhang, Pu Zhao, He Huang
Engineering better chimeric antigen receptor T cells. Experimental hematology & oncology 9 (1) (2020)
Huafang Wang, Ni Zhu, Xiaohang Ye, Limengmeng Wang, Binsheng Wang, Wei Shan, Xiaoyu Lai, Yamin Tan, Shan Fu, Haowen Xiao, He Huang
PTPN21-CDSlong isoform inhibits the response of acute lymphoblastic leukemia cells to NK-mediated lysis via the KIR/HLA-I axis. Journal of cellular biochemistry 121 (5-6) (2020)
Yiyun Wang, Yingying Yang, Ruimin Hong, Houli Zhao, Guoqing Wei, Wenjun Wu, Huijun Xu, Jiazhen Cui, Yanlei Zhang, Alex H Chang, Yongxian Hu, He Huang
A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia. Blood cancer journal 10 (10) (2020)
Luxin Yang, Yamin Tan, Jimin Shi, Yanmin Zhao, Jian Yu, Yongxian Hu, Xiaoyu Lai, Yang Yang, He Huang, Yi Luo
Prophylactic modified donor lymphocyte infusion after low-dose ATG-F-based haploidentical HSCT with myeloablative conditioning in high-risk acute leukemia: a matched-pair analysis. Bone marrow transplantation 56 (3) (2020)
Ruimin Hong, Houli Zhao, Yiyun Wang, Yu Chen, Hongliu Cai, Yongxian Hu, Guoqing Wei, He Huang
Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy. Bone marrow transplantation 56 (3) (2020)
Huafang Wang, Xiaohang Ye, Haowen Xiao, Ni Zhu, Cong Wei, Xiang Sun, Limengmeng Wang, Binsheng Wang, Xiaohong Yu, Xiaoyu Lai, Shan Fu, He Huang
PTPN21 Overexpression Promotes Osteogenic and Adipogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells but Inhibits the Immunosuppressive Function. Stem cells international 2019 (2019)
Guoqing Wei, Yongxian Hu, Chengfei Pu, Jian Yu, Yi Luo, Jimin Shi, Qu Cui, Wenjun Wu, Jinping Wang, Lei Xiao, Zhao Wu, He Huang
CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study. Annals of hematology 97 (5) (2018)
Binsheng Wang, Yu Lin, Yongxian Hu, Wei Shan, Senquan Liu, Yulin Xu, Hao Zhang, Shuyang Cai, Xiaohong Yu, Zhen Cai, He Huang
mTOR inhibition improves the immunomodulatory properties of human bone marrow mesenchymal stem cells by inducing COX-2 and PGE2. Stem cell research & therapy 8 (1) (2017)

He Huang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

He Huang